Live Breaking News & Updates on Skin and soft tissue infection

Stay informed with the latest breaking news from Skin and soft tissue infection on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Skin and soft tissue infection and stay connected to the pulse of your community

What's Behind Long-Term Antibiotic Prescribing for Acne?

"This study explored why dermatologists still prescribe a good number of long-term antibiotics for people with acne," the study's senior author Howa Yeung, MD, MSc, said in an interview.

United-states , University-of-pennsylvania , Pennsylvania , Japan , Philadelphia , Japanese , American , Davidj-margolis , Howa-yeung , Japanese-dermatological-association , American-academy-of-dermatology , Emory-university

FDA Accepts Application for a New HS Treatment

Bimekizumab is currently approved in the United States for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

United-states , Drug-administration , European-union , Biologics-license-application , Psoriasis , Psoriatic-arthritis , Rthropathic-psoriasis , Soriatic-arthropathy , Sa , Phototherapy , Ight-therapy

Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa

Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.

United-states , California , University-of-southern-california , Boston , Massachusetts , American , Martinaj-porter , P-jenniferl-hsiao , Los-angeles , Beth-israel-deaconess-medical-center , Harvard-medical-school , American-academy-of-dermatology

Longer IV Ertapenem Course Beneficial for Recalcitrant HS

2019 treatment guidelines published recommended ertapenem as a highly effective third-line therapy limited to a shorter course, as rescue therapy or during surgical planning.

New-york , United-states , University-of-southern-california , California , San-francisco , American , Stevenr-cohen , Los-angeles , Jenniferl-hsiao , Haleyb-naik , Albert-einstein-college-of-medicine , University-of-california

One-a-Day Pill for Alopecia Recommended for NHS Use

NICE said there is unequal treatment for people with severe alopecia areata across England and Wales and its approval of ritlecitinib could benefit up to 14,000 people.

United-kingdom , National-institute-for-health , Regulatory-agency , Pfizer , National-institute , Care-excellence , Alopecia-united , Sue-schilling , Alopecia , Alopecia-areata , Uk-national-health-service